This act authorizes the Minister of Health to spend up to $2.5 billion from the Consolidated Revenue Fund for COVID-19 testing expenses starting January 1, 2022, and to transfer COVID-19 tests or testing instruments acquired after April 1, 2021, to provinces, territories, or other Canadian entities.